Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2006; 12(29): 4706-4709
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4706
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4706
Table 1 Primers sequences of p53 gene exons 5-8
| Primers | Sequences | |
| Sense | Anti-sense | |
| Exon 5 | 5′-TGT TCA CTT GTG CCC TGA CT-3′ | 5′-CAG CCC TGT CGT CTC TCC AG-3′ |
| Exon 6 | 5′-ACA GGG CTG GTT GCC CAG GGT-3′ | 5′-CTC CCAGAG ACC CCA GTT GC-3′ |
| Exon 7 | 5′-GGT CTC CCC AAG GCG CAC TGG-3′ | 5′-AGG CTG GGG GCA CAG CAG GCC-3′ |
| Exon 8 | 5′-ATT TCC TTA CTG CCT CTT GC-3′ | 5′-AAG TGA ATC TGA GGC ATA AC-3 |
Table 2 Correlation of mutation status of p53 gene and P53 protein expression with pathologic parameters in cholangiocarcinoma
| Pathologiccharacter | n | p53 gene mutation | P53 protein expression | ||
| Positive (n, %) | P vaule | Positive (n, %) | P vaule | ||
| Pathologic type | |||||
| Tubular | 18 | 11 (61.1) | 10 (55.6) | ||
| carcinoma | |||||
| Papillary | 9 | 6 (66.7) | 5 ( 55.6) | ||
| carcinoma | |||||
| Mucoid | 4 | 2 (50.0) | 2 (50.0) | ||
| carcinoma | |||||
| Non-differentiated | 5 | 3 (60.0) | > 0.05 | 2 (40.0) | > 0.05 |
| carcinoma | |||||
| Differentiation | |||||
| Well -Moderate | 25 | 13 (52.0) | 9 (36.0) | ||
| Poor | 11 | 9 (81.8) | > 0.05 | 10 (90.9) | < 0.05a |
| Invasion | |||||
| T1 | 16 | 7 (43.8) | 2 (12.5) | ||
| T2 | 10 | 8 (80.0) | 8 (80.0) | ||
| T3 | 10 | 7 (70.0) | > 0.05 | 9 (90.0) | < 0.05c |
| Lymph node metastasis | |||||
| N0 | 3 | 2 (66.7) | 0 (0) | ||
| N1 | 33 | 20 (60.6) | > 0.05 | 19 (57.5) | > 0.05 |
- Citation: Liu XF, Zhang H, Zhu SG, Zhou XT, Su HL, Xu Z, Li SJ. Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol 2006; 12(29): 4706-4709
- URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4706.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i29.4706
